Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 2/2013

01-04-2013 | Original Article

Impaired capsular polysaccharide is relevant to enhanced biofilm formation and lower virulence in Streptococcus pneumoniae

Authors: Liang Qin, Yutaka Kida, Yoshihiro Imamura, Koichi Kuwano, Hiroshi Watanabe

Published in: Journal of Infection and Chemotherapy | Issue 2/2013

Login to get access

Abstract

Streptococcus pneumoniae has been reported to form biofilms. Many different surface molecules, including capsular polysaccharide (CPS), may play a fundamental role in pneumococcal biofilm development. We designed a CPS mutant, TIGR4cps4D, from the TIGR4 strain and detected enhanced biofilm formation. The pathogenic diversities of the mutant were also investigated with the in vitro expression levels of pavA, lytA, IgA1, piaA, psaA, ply, and spxB. The mean OD595 of TIGR4cps4D biofilm was 1.77 and 1.74, whereas that of TIGR4 was 0.76 and 0.33 on day 1 and day 2, respectively. Scanning electron microscopy and confocal laser scanning microscopy showed TIGR4cps4D formed a biofilm that was significantly thicker than that formed by TIGR4 (~12.22 vs. ~6.29 μm). Compared to TIGR4, the gene expression of lytA, IgA1, and, psaA in TIGR4cps4D was 1.9 × 10−5-, 2.4 × 10−5-, and 3.2 × 10−3 fold lower under the planktonic condition, and 1.9 × 10−5- and 9.7 × 10−5 fold lower in biofilms, respectively. Furthermore, TIGR4cps4D seemed to induce less cell death, compared to the results of TIGR4 (21.38 vs. 33.47 %, after a 5-h exposure; P < 0.05). Our data indicate that impaired pneumococcal CPS may increase biofilm formation and be involved in inhibition of virulence, possibly by influencing the gene expression.
Literature
1.
go back to reference Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltim). 1990;69:307–16. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltim). 1990;69:307–16.
2.
go back to reference Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77–83.PubMedCrossRef Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77–83.PubMedCrossRef
3.
go back to reference Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979–1990). Clin Infect Dis. 1992;15:99–105.PubMedCrossRef Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979–1990). Clin Infect Dis. 1992;15:99–105.PubMedCrossRef
4.
go back to reference Rello J, Rodriguez R, Jubert P, Alvarez B. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis. 1996;23:723–8.PubMedCrossRef Rello J, Rodriguez R, Jubert P, Alvarez B. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis. 1996;23:723–8.PubMedCrossRef
5.
go back to reference Restrepo MI, Jorgensen JH, Mortensen EM, Anzueto A. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy. Curr Opin Infect Dis. 2001;14:703–9.PubMedCrossRef Restrepo MI, Jorgensen JH, Mortensen EM, Anzueto A. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy. Curr Opin Infect Dis. 2001;14:703–9.PubMedCrossRef
6.
go back to reference Moscoso M, Garcia E, Lopez R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol. 2006;188:7785–95.PubMedCrossRef Moscoso M, Garcia E, Lopez R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol. 2006;188:7785–95.PubMedCrossRef
7.
go back to reference Donlan RM, Piede JA, Heyes CD, Sanii L, Murga R, Edmonds P, et al. Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol. 2004;70:4980–8.PubMedCrossRef Donlan RM, Piede JA, Heyes CD, Sanii L, Murga R, Edmonds P, et al. Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol. 2004;70:4980–8.PubMedCrossRef
8.
go back to reference Allegrucci M, Hu FZ, Shen K, Hayes J, Ehrlich GD, Post JC, et al. Phenotypic characterization of Streptococcus pneumoniae biofilm development. J Bacteriol. 2006;188:2325–35.PubMedCrossRef Allegrucci M, Hu FZ, Shen K, Hayes J, Ehrlich GD, Post JC, et al. Phenotypic characterization of Streptococcus pneumoniae biofilm development. J Bacteriol. 2006;188:2325–35.PubMedCrossRef
9.
go back to reference Allegrucci M, Sauer K. Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms. J Bacteriol. 2007;189:2030–8.PubMedCrossRef Allegrucci M, Sauer K. Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms. J Bacteriol. 2007;189:2030–8.PubMedCrossRef
10.
go back to reference McEllistrem MC, Ransford JV, Khan SA. Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone. J Clin Microbiol. 2007;45:97–101.PubMedCrossRef McEllistrem MC, Ransford JV, Khan SA. Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone. J Clin Microbiol. 2007;45:97–101.PubMedCrossRef
11.
go back to reference Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.PubMedCrossRef Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.PubMedCrossRef
13.
go back to reference Kolkman MA, van der Zeijst BA, Nuijten PJ. Diversity of capsular polysaccharide synthesis gene clusters in Streptococcus pneumoniae. J Biochem (Tokyo). 1998;123:937–45.CrossRef Kolkman MA, van der Zeijst BA, Nuijten PJ. Diversity of capsular polysaccharide synthesis gene clusters in Streptococcus pneumoniae. J Biochem (Tokyo). 1998;123:937–45.CrossRef
14.
go back to reference Garcia E, Llull D, Munoz R, Mollerach M, Lopez R. Current trends in capsular polysaccharide biosynthesis of Streptococcus pneumoniae. Res Microbiol. 2000;151:429–35.PubMedCrossRef Garcia E, Llull D, Munoz R, Mollerach M, Lopez R. Current trends in capsular polysaccharide biosynthesis of Streptococcus pneumoniae. Res Microbiol. 2000;151:429–35.PubMedCrossRef
15.
go back to reference Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2006;2:e31.PubMedCrossRef Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2006;2:e31.PubMedCrossRef
16.
go back to reference Morona JK, Paton JC, Miller DC, Morona R. Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol Microbiol. 2000;35:1431–42.PubMedCrossRef Morona JK, Paton JC, Miller DC, Morona R. Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol Microbiol. 2000;35:1431–42.PubMedCrossRef
17.
go back to reference Morona JK, Morona R, Miller DC, Paton JC. Mutational analysis of the carboxy-terminal (YGX)4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae. J Bacteriol. 2003;185:3009–19.PubMedCrossRef Morona JK, Morona R, Miller DC, Paton JC. Mutational analysis of the carboxy-terminal (YGX)4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae. J Bacteriol. 2003;185:3009–19.PubMedCrossRef
18.
go back to reference Jiang SM, Wang L, Reeves PR. Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters. Infect Immun. 2001;69:1244–55.PubMedCrossRef Jiang SM, Wang L, Reeves PR. Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters. Infect Immun. 2001;69:1244–55.PubMedCrossRef
19.
go back to reference Coffey TJ, Enright MC, Daniels M, Morona JK, Morona R, Hryniewicz W, et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol. 1998;27:73–83.PubMedCrossRef Coffey TJ, Enright MC, Daniels M, Morona JK, Morona R, Hryniewicz W, et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol. 1998;27:73–83.PubMedCrossRef
20.
go back to reference Nesin M, Ramirez M, Tomasz A. Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis. 1998;177:707–13.PubMedCrossRef Nesin M, Ramirez M, Tomasz A. Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis. 1998;177:707–13.PubMedCrossRef
21.
go back to reference Tomasz A. New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae. Am J Med. 1999;107:55S–62S.PubMedCrossRef Tomasz A. New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae. Am J Med. 1999;107:55S–62S.PubMedCrossRef
22.
go back to reference LeMessurier KS, Ogunniyi AD, Paton JC. Differential expression of key pneumococcal virulence genes in vivo. Microbiology. 2006;152:305–11.PubMedCrossRef LeMessurier KS, Ogunniyi AD, Paton JC. Differential expression of key pneumococcal virulence genes in vivo. Microbiology. 2006;152:305–11.PubMedCrossRef
23.
go back to reference Mortier-Barriere I, de Saizieu A, Claverys JP, Martin B. Competence-specific induction of recA is required for full recombination proficiency during transformation in Streptococcus pneumoniae. Mol Microbiol. 1998;27:159–70.PubMedCrossRef Mortier-Barriere I, de Saizieu A, Claverys JP, Martin B. Competence-specific induction of recA is required for full recombination proficiency during transformation in Streptococcus pneumoniae. Mol Microbiol. 1998;27:159–70.PubMedCrossRef
24.
go back to reference Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA. 2003;100:4215–20.PubMedCrossRef Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA. 2003;100:4215–20.PubMedCrossRef
25.
go back to reference Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001;293:498–506.PubMedCrossRef Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001;293:498–506.PubMedCrossRef
26.
go back to reference Mayer MP. A new set of useful cloning and expression vectors derived from pBlueScript. Gene (Amst). 1995;163:41–6.CrossRef Mayer MP. A new set of useful cloning and expression vectors derived from pBlueScript. Gene (Amst). 1995;163:41–6.CrossRef
27.
go back to reference Qin L, Watanabe H, Yoshimine H, Guio H, Watanabe K, Kawakami K, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan. Epidemiol Infect. 2006;134:1188–94.PubMedCrossRef Qin L, Watanabe H, Yoshimine H, Guio H, Watanabe K, Kawakami K, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan. Epidemiol Infect. 2006;134:1188–94.PubMedCrossRef
28.
go back to reference Yother J, McDaniel LS, Briles DE. Transformation of encapsulated Streptococcus pneumoniae. J Bacteriol. 1986;168:1463–5.PubMed Yother J, McDaniel LS, Briles DE. Transformation of encapsulated Streptococcus pneumoniae. J Bacteriol. 1986;168:1463–5.PubMed
29.
go back to reference Berry AM, Yother J, Briles DE, Hansman D, Paton JC. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun. 1989;57:2037–42.PubMed Berry AM, Yother J, Briles DE, Hansman D, Paton JC. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun. 1989;57:2037–42.PubMed
30.
go back to reference Inokuchi T, Yokoyama R, Higashi R, Takahashi Y, Miyajima S. Ultrastructure of the perineurial cell of the sciatic nerve in rats—a transmission and scanning electron microscopic study. Kurume Med J. 1991;38:221–32.PubMedCrossRef Inokuchi T, Yokoyama R, Higashi R, Takahashi Y, Miyajima S. Ultrastructure of the perineurial cell of the sciatic nerve in rats—a transmission and scanning electron microscopic study. Kurume Med J. 1991;38:221–32.PubMedCrossRef
31.
go back to reference Kaji C, Watanabe K, Apicella MA, Watanabe H. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med. 2008;214:121–8.PubMedCrossRef Kaji C, Watanabe K, Apicella MA, Watanabe H. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med. 2008;214:121–8.PubMedCrossRef
32.
go back to reference Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280:295–8.PubMedCrossRef Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280:295–8.PubMedCrossRef
33.
go back to reference Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.PubMedCrossRef Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.PubMedCrossRef
34.
go back to reference Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW. Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol. 2008;34:163–73.PubMedCrossRef Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW. Pneumococcal surface adhesin A (PsaA): a review. Crit Rev Microbiol. 2008;34:163–73.PubMedCrossRef
35.
go back to reference Schembri MA, Dalsgaard D, Klemm P. Capsule shields the function of short bacterial adhesins. J Bacteriol. 2004;186:1249–57.PubMedCrossRef Schembri MA, Dalsgaard D, Klemm P. Capsule shields the function of short bacterial adhesins. J Bacteriol. 2004;186:1249–57.PubMedCrossRef
36.
go back to reference Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4:21.PubMedCrossRef Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4:21.PubMedCrossRef
37.
go back to reference Morona JK, Miller DC, Morona R, Paton JC. The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. J Infect Dis. 2004;189:1905–13.PubMedCrossRef Morona JK, Miller DC, Morona R, Paton JC. The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. J Infect Dis. 2004;189:1905–13.PubMedCrossRef
38.
go back to reference Kausmally L, Johnsborg O, Lunde M, Knutsen E, Havarstein LS. Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis. J Bacteriol. 2005;187:4338–45.PubMedCrossRef Kausmally L, Johnsborg O, Lunde M, Knutsen E, Havarstein LS. Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis. J Bacteriol. 2005;187:4338–45.PubMedCrossRef
39.
go back to reference Wani JH, Gilbert JV, Plaut AG, Weiser JN. Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun. 1996;64:3967–74.PubMed Wani JH, Gilbert JV, Plaut AG, Weiser JN. Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun. 1996;64:3967–74.PubMed
40.
go back to reference Boulnois GJ, Paton JC, Mitchell TJ, Andrew PW. Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol Microbiol. 1991;5:2611–6.PubMedCrossRef Boulnois GJ, Paton JC, Mitchell TJ, Andrew PW. Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol Microbiol. 1991;5:2611–6.PubMedCrossRef
41.
go back to reference Steinfort C, Wilson R, Mitchell T, Feldman C, Rutman A, Todd H, et al. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun. 1989;57:2006–13.PubMed Steinfort C, Wilson R, Mitchell T, Feldman C, Rutman A, Todd H, et al. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun. 1989;57:2006–13.PubMed
42.
go back to reference Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Muller E, Rohde M. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73:4653–67.PubMedCrossRef Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Muller E, Rohde M. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73:4653–67.PubMedCrossRef
Metadata
Title
Impaired capsular polysaccharide is relevant to enhanced biofilm formation and lower virulence in Streptococcus pneumoniae
Authors
Liang Qin
Yutaka Kida
Yoshihiro Imamura
Koichi Kuwano
Hiroshi Watanabe
Publication date
01-04-2013
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 2/2013
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-012-0495-3

Other articles of this Issue 2/2013

Journal of Infection and Chemotherapy 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine